Racemic ketamine

DRUG3 trials

Sponsors

Lund University, The George Institute, Yale University

Conditions

Abnormal Vascular FlowDepressionHealthyTreatment Resistant Depression

Phase 3

PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study

RecruitingNCT06713616

Yale UniversityDepression

Start: 2025-01-27End: 2030-12-31Target: 400Updated: 2026-02-17

Phase 4

Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant Depression

RecruitingNCT06278779

The George InstituteTreatment Resistant Depression

Start: 2024-06-03End: 2027-04-30Target: 162Updated: 2025-06-03

Unknown Phase

Racemic Ketamine Versus S-ketamine With Arterial Spin Labeling (ASL)-MRI in Healthy Volunteers

CompletedNCT01506921

Lund UniversityAbnormal Vascular Flow, Healthy

Start: 2011-05-31End: 2012-02-29Target: 14Updated: 2012-02-22